AAAAAA

   
Results: 1-11 |
Results: 11
OXIDATIVE STRESS IN CHRONIC-RENAL-FAILURE
Authors: HASSELWANDER O YOUNG IS
Citation: O. Hasselwander et Is. Young, OXIDATIVE STRESS IN CHRONIC-RENAL-FAILURE, Free radical research, 29(1), 1998, pp. 1-11
SERUM PARAOXONASE AND PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE IN CHRONIC-RENAL-FAILURE
Authors: HASSELWANDER O MCMASTER D FOGARTY DG MAXWELL AP NICHOLLS DP YOUNG IS
Citation: O. Hasselwander et al., SERUM PARAOXONASE AND PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE IN CHRONIC-RENAL-FAILURE, Clinical chemistry, 44(1), 1998, pp. 179-181
ANTIOXIDANT CAPACITY OF HDL IN PATIENTS WITH CHRONIC-RENAL-FAILURE
Authors: HASSELWANDER O YOUNG IS MCENENY J MCMASTER D FOGARTY DG NICHOLLS DP MAXWELL AP
Citation: O. Hasselwander et al., ANTIOXIDANT CAPACITY OF HDL IN PATIENTS WITH CHRONIC-RENAL-FAILURE, Journal of the American Society of Nephrology, 8, 1997, pp. 2879-2879
PARAOXONASE SPECIFIC ACTIVITY IS REDUCED IN PATIENTS WITH CHRONIC-RENAL-FAILURE
Authors: HASSELWANDER O YOUNG IS MACKNESS MI ARROL S MCMASTER D FOGARTY DG NICHOLLS DP MAXWELL AP
Citation: O. Hasselwander et al., PARAOXONASE SPECIFIC ACTIVITY IS REDUCED IN PATIENTS WITH CHRONIC-RENAL-FAILURE, Journal of the American Society of Nephrology, 8, 1997, pp. 2880-2880
PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE (PAF-AH) IN PATIENTS WITH CHRONIC-RENAL-FAILURE
Authors: HASSELWANDER O YOUNG IS MCMASTER D FOGARTY DG NICHOLLS DP MAXWELL AP
Citation: O. Hasselwander et al., PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE (PAF-AH) IN PATIENTS WITH CHRONIC-RENAL-FAILURE, Journal of the American Society of Nephrology, 8, 1997, pp. 2881-2881
SYNTHESIS OF 4-AZA-5,6-DIMETHYLBENZIMIDAZOLE AND BIOSYNTHETIC PREPARATION OF 4-AZA-5,6-DIMETHYLBENZIMIDAZOLYLCOBAMIDE AND 7-AZA-5,6-DIMETHYLBENZIMIDAZOLYLCOBAMIDE
Authors: RENZ P PFITZNER I ENDRES B HASSELWANDER O
Citation: P. Renz et al., SYNTHESIS OF 4-AZA-5,6-DIMETHYLBENZIMIDAZOLE AND BIOSYNTHETIC PREPARATION OF 4-AZA-5,6-DIMETHYLBENZIMIDAZOLYLCOBAMIDE AND 7-AZA-5,6-DIMETHYLBENZIMIDAZOLYLCOBAMIDE, Zeitschrift fur Naturforschung. C, A journal of biosciences, 52(5-6), 1997, pp. 287-291
OXIDATION OF LOW-DENSITY-LIPOPROTEIN AND ATHEROSCLEROSIS IN CHRONIC-RENAL-FAILURE
Authors: HASSELWANDER O YOUNG IS
Citation: O. Hasselwander et Is. Young, OXIDATION OF LOW-DENSITY-LIPOPROTEIN AND ATHEROSCLEROSIS IN CHRONIC-RENAL-FAILURE, Medical hypotheses, 49(5), 1997, pp. 389-395
PARAOXONASE ACTIVITY IN CHRONIC-RENAL-FAILURE
Authors: HASSELWANDER O MCMASTER D FOGARTY DG MAXWELT AP NICHOLLS DP YOUNG IS
Citation: O. Hasselwander et al., PARAOXONASE ACTIVITY IN CHRONIC-RENAL-FAILURE, Kidney international, 52(4), 1997, pp. 1119-1119
PARAOXONASE ACTIVITY IS REDUCED IN CHRONIC-RENAL-FAILURE
Authors: YOUNG IS HASSELWANDER O MCMASTER D FOGARTY DG MAXWELL AP NICHOLLS DP
Citation: Is. Young et al., PARAOXONASE ACTIVITY IS REDUCED IN CHRONIC-RENAL-FAILURE, Atherosclerosis, 135(1), 1997, pp. 15-15
PARAOXONASE ACTIVITY AND PHENOTYPE IN RENAL-FAILURE
Authors: HASSELWANDER O MCMASTER D FOGARTY DG MAXWELL AP NICHOLLS DP YOUNG IS
Citation: O. Hasselwander et al., PARAOXONASE ACTIVITY AND PHENOTYPE IN RENAL-FAILURE, Atherosclerosis, 134(1-2), 1997, pp. 212-212
THE EFFECT OF CYCLOSPORINE ON SERUM-LIPIDS AND THE SUSCEPTIBILITY OF LDL TO OXIDATION IN RENAL-TRANSPLANT RECIPIENTS
Authors: YOUNG IS MCKEOWN A HASSELWANDER O MCENENY J LIGHTBODY JH LOUGHREY CM FOGARTY D MAXWELL AP NICHOLLS DP
Citation: Is. Young et al., THE EFFECT OF CYCLOSPORINE ON SERUM-LIPIDS AND THE SUSCEPTIBILITY OF LDL TO OXIDATION IN RENAL-TRANSPLANT RECIPIENTS, Atherosclerosis, 128(2), 1997, pp. 17-17
Risultati: 1-11 |